NCT04611568Active, not recruiting
War on Melanoma™ Public Health & Education Campaign
Educational Program for the Early Detection of Melanoma in Oregon
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
This trial studies how well a health educational campaign works in increasing early detection of melanoma in Oregon. The health educational campaign may provide information to help people learn about the early signs of melanoma. Increased education in Oregon may decrease the number of people who die from melanoma and increase the number of melanomas that are identified at an earlier stage.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 75000 (estimated)
- First submitted
- 28 Oct 2020
- Start date
- 14 May 2019
- Primary completion date
- 30 Dec 2026
- Lead sponsor
- OHSU Knight Cancer Institute
- Diseases
- Melanoma, Childhood cancers
- NCT number
- NCT04611568
What you commit to
- Study type: Interventional
- Planned participants: 75000
- From 14 May 2019 to the primary completion date, 30 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No one will be intentionally excluded
Who the study is looking for
- Individuals, melanoma patients, skin service providers and health care providers interested in awareness and educational campaign
Age in the registry: 12 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| OHSU Knight Cancer Institute Coordinator of this site? Confirm its status | Portland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.